NCT00078975 2018-09-14
3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
University Health Network, Toronto
Phase 2 Completed
Clinical Trials
6 trialsNCT00288093 2017-08-18
3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Completed
NCT00075504 2015-09-28
Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00077545 2013-10-08
3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
National Cancer Institute (NCI)
Phase 2 Completed
NCT00085371 2013-10-08
Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
National Cancer Institute (NCI)
Phase 2 Completed
NCT00064051 2013-08-02
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed